Pharmaceutical

Curevo procures $110m and former-GSK exec for shingles vaccine candidate

GSK’s shingles vaccine Shingrix passed $1bn in sales last year as Curevo aims to grasp market share.

Mar 19, 2025 - 06:00
Curevo procures $110m and former-GSK exec for shingles vaccine candidate
GSK’s shingles vaccine Shingrix passed $1bn in sales last year as Curevo aims to grasp market share.
Read the original article

Tags:

Previous Article

Opko and Entera focus on oral care for obesity and metabolic disorders

Next Article

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: More than 200 FDA staffers have retired in less than a year

STAT+: More than 200 FDA staffers have retired in less ...

Jun 6, 2023

STAT+: Pharmalittle: We’re reading about RSV vax link to GSB, a Pfizer donation, and more

STAT+: Pharmalittle: We’re reading about RSV vax link t...

Mar 2, 2024

USPTO grants Notice of Allowance for Tenax Therapeutics’ oral levosimendan

USPTO grants Notice of Allowance for Tenax Therapeutics...

Jun 1, 2023